During the past decade, The Gastroenterology Group conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Gastroenterology Group" #1 sponsor was "Celgene" with 3 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Guardant Health, Inc." with 1 trials sponsored and "Ironwood Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Gastroenterology Group" #1 collaborator was "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "The Gastroenterology Group" are "Crohn Disease" (3 trials), "Liver Fibrosis" (2 trials), "Nonalcoholic Fatty Liver Disease (NAFLD)" (2 trials), "Nonalcoholic Steatohepatitis" (2 trials) and "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "The Gastroenterology Group" in a lesser frequency.

Most popular intervention types in "The Gastroenterology Group" are "Drug" (8 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Ozanimod" (3 trials), "BMS-986036" (2 trials), "IW-3718" (1 trials) and "Mirikizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Gastroenterology Group" are 9 trials for "All" genders.

Currently, there are NaN active trials in "The Gastroenterology Group". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in The Gastroenterology Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Gastroenterology Group, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".